1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0706002781, ACS IRG 58-012-49, NCT00730158
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J1161, NCT01317199
|
|
3.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: Application ID 213, NCT01585246
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CASE-CCF-7348, CCF-7348, NCT00243022, CASE1304200
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Germanium, NCT00651417
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 4P-07-3, NCT00669656
|
|
7.
|
Phase: Phase II Type: Prevention Status: Active Age: 30 to 80 Sponsor: NCI, Other Protocol IDs: MCC-15008, R01 CA12060-01A1, NCT00596011
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KLT-PANC-001, NCT00733850
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 50 to 64 Sponsor: NCI, Other Protocol IDs: 0806M36121, NCT00917735
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J0822, NCT00982319
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C10-069, NCT01483586
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 40 and over Sponsor: NCI Protocol IDs: MAYO-MC084C, MC084C, R01-CA-132991
|
|
13.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC20100308H, NCT01705652
|
|
14.
|
Phase: Phase I Type: Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WCI1549-08, NCT01116336
|
|
15.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: BCC-GI-10 Curcumin, NCT01294072
|
|
16.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 to 85 Sponsor: NCI Protocol IDs: NCI-2013-00536, 00011821, R01CA134620, NCT00641147
|
|
17.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08.0040, BCC-LUN-07-002, NCT00681512
|
|
18.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 90 Sponsor: NCI, Other Protocol IDs: H08-081, 1R21CA137545-01A2, FWCC, NCT01160302
|
|
19.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention, Screening Status: Active Age: 50 to 75 Sponsor: NCI, Other Protocol IDs: P01 CA090890, NCT01344330
|
|
20.
|
Phase: No phase specified Type: Prevention Status: Active Age: 23 to 40 Sponsor: Other Protocol IDs: 2007C0109, NCT01162642
|
|
21.
|
Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EH0524BlackCohosh, NCT01628536
|
|
22.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 to 89 Sponsor: Other Protocol IDs: STU68227, NCT01735942
|